Study shows preexisting cross-reactive antibodies against common cold coronaviruses may protect against SARS-CoV-2 and are more common in children
9 Nov, 2020 | 01:28h | UTCPreexisting and de novo humoral immunity to SARS-CoV-2 in humans – Science
Commentaries: Pre-existing coronavirus antibodies could help protect children against new pandemic strain – Francis Crick Institute AND Expert reaction to study looking at pre-existing coronavirus antibodies – Science Media Centre
Commentary on Twitter
Do some people have cross-reactive antibodies to #SARSCoV2? If so, who are they? And are these cross-reactive Abs protective against #COVID19? A fascinating study by @KevinWNg et al provides answers. Thread. (1/n)
https://t.co/U9UVrwztX5— Prof. Akiko Iwasaki (@VirusesImmunity) November 7, 2020